Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...

Compared with sham, transnasal dry air flow at 10 L per minute using the Mi-Helper device was effective in treating acute ...

Delivering room-temperature air through the nose to cool the sphenopalatine ganglion taps into a powerful neuromodulatory ...

For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged.

Migraine disease affects millions of Americans, but treatments often cause side effects that hinder sufferers' ability to function.

The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital ...

The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.

A coverage with evidence development (CED) study demonstrated significant and clinically meaningful benefits in patients with migraine treated with remote electrical neuromodulation (REN). Health ...

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive ...